The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children

Journal of the Medical Association of Thailand

Volumn 82, Issue SUPPL., 1999, Pages

  Tangnararatchakit, Kanchana ^a   Tapaneya Olarn, Chaleomsri ^a   Tapaneya Olarn, Wiwat ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Children; Lupus Nephritis; Pulse Cyclophosphamide; Treatment

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ADOLESCENT; ARTICLE; CHILD; FEMALE; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; CHILD; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS NEPHRITIS; MALE; PREDNISOLONE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0011830215     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Wallace DJ, Podell T, Weiner DPG, Klineraberg JL, Forougesh S, Dubois EL. Systemic lupus erythematosus-survival pattern: experience with 60 patients. JAMA 1981; 245:934-8.
2. Nived O, Sturfelt G, Wollheim F. Systemic lupus erythematosus and infections: a controlled and prospective study including an epidemiological group. Q J Med 1985; 218:271-87.
3. Steinberg AD, Gourley MF, Klinman DM, Tsoko GC, Scott DE, Krieg AM. Systemic lupus erythematosus. Ann Intern Med 1991; 115:548-59.
4. Tapaneya-Olarn W. Renal involvement in SLE. In: Lolekha S, Direkwatanachai C, Tuchinda M, eds. Clinical immunology and allergy. Bangkok: Chaichareon Publisher, 1991:80-2.
5. Caeiro F, Michielson FMC, Bernstein BH, King KK, Hanson V. Systemic lupus erythematosus in childhood. Ann Rheum Dis 1981; 40:325-31.
6. Abeles M, Urman JD, Weinstein A, Lowenstein M, Rothfield NF. Systemic lupus erythematosus in younger patient: survival studies. J Rheumatol 1980; 7:512-22.
7. Yan LY, Chen WP, Lin CY. Lupus nephritis in children-a review of 167 patients. Pediatrics 1994; 94:335-40.
8. Baqi N, Moazami S, Singh A, et al. Lupus nephritis in children: a longtitudinal study of prognostic factors and therapy. J Am Soc Nephrol 1996; 6: 924-9.
9. Sztejnbok M, Stewart A, Diamond H, Kaplan D. Azathioprine in the treatment of systemic lupus erythematosus: a controlled trial. Arthritis Rheum 1971; 14:639-45.
10. Donadio JV Jr, Holley KE, Ferguson RH, Ilstrup DM. Progressive lupus glomerulonephritis: treatment with prednisolone and combined prednisolone and cyclophosphamide. Mayo Clin Proc 1976; 51:484-94.
11. Cade R, Spooner G, Schlein E, et al. Comparison of azathioprine, prednisolone and heparin alone or combined in treating lupus nephritis. Nephron 1973; 10:37-56.
12. Steinberg AD, Decker JL. A double-blind controlled trial comparing cyclophosphamide, azathioprine and placebo in the treatment of lupus glomerulonephritis. Arthritis Rheum 1974; 17: 923-37.
13. Dinant HJ, Decker JL, Klippel JH, Balow JE, Plotz PH, Steinberg AD. Alternative modes of cyclophosphamide and azathioprine therapy in lupus nephritis. Ann Intern Med 1982; 96:728-36.
14. Felson DT, Anderson J. Evidence of the superiority of immunosuppressive drugs and prednisolone over prednisolone alone in lupus nephritis: results of pooled analysis. N Engl J Med 1984; 311: 1528-33.
15. Bamsal VK, Beto J. Treatment of lupus nephritis: a meta-analysis of clinical trials. Am J Kidney Dis 1997; 29:193-9.
16. Balow JE, Austin HA, Muenz LR, et al. Effect of treatment on the evolution of renal abnormalities in lupus nephritis. N Engl J Med 1984; 311:491-5.
17. Austin HA, Klippel JH, Balow JE, et al. Therapy of lupus nephritis controlled trial of prednisolone and cytotoxic drugs. N Engl J Med 1986; 314:614-9.
18. McCune WJ, Golbus J, Zeldes W, Bohlke P, Dunne R, Fox DA. Clinical and immunological effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus. N Engl J Med 1988; 318:1423-31.
19. Sanguansakkosol Y. Pulse intravenous cyclophosphamide therapy in SLE. In: Indraprasit S, Tapaneya-Olarn W, Tapaneya-Olarn C, eds. Tropical renal diseases and management of common renal diseases in Thailand. Bangkok: Pimsuoy Printing. 1991:81-90.
20. Martinelli R, Perira LSC, Santos ESC, Rocha H. Clinical effects of intermittent intravenous cyclophosphamide in severe systemic lupus erythematosus. Nephron 1996; 74:313-7.
21. Lehman TJA, Sherry DD, Wagner-Weiner L. et al. Intermittent intravenous cyclophosphamide therapy for lupus nephritis. J Pediatr 1989; 114:1055-60.
22. Yan DC, Chou CC, Tsai MJ. Chaing BL. Tsau YK. Hsieh KH. Intravenous cyclophosphamide pulse therapy on children with severe active lupus nephritis. Acta Paediatr Surg 1995; 36:203-9.
23. Saberi MS, Jones BA. Remission of infantile systemic lupus erythematosus with intravenous cyclophosphamide. Pediatr Nephrol 1998; 12:136-8.
24. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1276-7.
25. Balow JE, Austin HA, Tsokos GC, Antonovych TT, Steinberg AD, Klippel JH. Lupus nephritis. Ann Intern Med 1987; 106:79-94.
26. Sessoms SL, Kavarsky J. Monthly intravenous cyclophosphamide in the treatment of severe systemic lupus erythematosus. Clin Exp Rheumatol 1984; 2:249-51.
27. Steinberg AD, Steinberg SC. Long term preservation of renal function in patients with lupus nephritis receiving treatment included cyclophosphamide versus those treated with prednisolone alone. Arthritis Rheum 1991; 34:945-59.
28. Valeri A, Radhakrishnan J, Ester D, et al. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study. Clin Nephrol 1994; 42:71-8.
29. Belmont HM, Storch M, Buyon J, Abramson S. New York University Hospital for joint disease experience with intravenous cyclophosphamide treatment efficacy in steroid unresponsive lupus nephritis. Lupus 1995; 4:104-8.
30. Gourly MF, Austin HA, Scott D, et al. Methylprednisolone and cyclophosphamide, alone or combination, in patients with lupus nephritis: a randomized, controlled trial. Ann Intern Med 1996; 125:549-57.